Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Twin SUBLIVAC Grasses Clinical Efficacy Study.

Trial Profile

Twin SUBLIVAC Grasses Clinical Efficacy Study.

Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Allergy immunotherapy (Primary)
  • Indications Allergic asthma; Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors HAL Allergy
  • Most Recent Events

    • 15 Sep 2009 Actual end date (1 Oct 2007) added as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Mar 2008 The expected completion date for this trial is now 1 Nov 2009, reported by ClinicalTrials.gov. Planned patient number also updated.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top